Search details
1.
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Lancet Infect Dis
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38614117
2.
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial.
Lancet Infect Dis
; 23(11): 1313-1322, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37475116
3.
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial.
Sci Bull (Beijing)
; 68(20): 2448-2455, 2023 10 30.
Article
in English
| MEDLINE | ID: mdl-37743201
Results
1 -
3
de 3
1
Next >
>>